LEVERKUSEN (dpa-AFX) - Bayer HealthCare (BAYZF.PK) announced that it has entered into a definitive agreement to sell its equine products Legend/Hyonate (hyaluronate sodium) and Marquis (ponazuril) to Merial, Inc. The company said these equine products have no strategic relevance for its business and represent less than 2 percent of worldwide sales.
Hyaluronate sodium, marketed worldwide for over two decades as Legend or Hyonate, is an injectable solution that treats noninfectious joint dysfunction in horses. Marquis (ponazuril) Antiprotozoal Oral Paste, marketed in North America for over a decade, treats equine protozoal myeloencephalitis - a disease that affects the central nervous system in horses.
Copyright RTT News/dpa-AFX